Bulletin 2011/31 - European Patent Office
06.01.2013 • Views
Share Embed Flag

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

(30) 17.10.2008 KR 20080101932<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG ZUR PRÄVENTION UND BEHAND-<br />

LUNG VON DIABETES ODER ADIPOSITAS<br />

MIT EINER VERBINDUNG ZUR HEMMUNG<br />

DER DIPEPTIDYLPEPTIDASE-IV-AKTIVI-<br />

TÄT UND ANDEREN ANTIDIABETIKA ODER<br />

ANTIADIPOSITA ALS WIRKSTOFFE<br />

• PHARMACEUTICAL COMPOSITION FOR<br />

PREVENTION AND TREATMENT OF DIA-<br />

BETES OR OBESITY COMPRISING A<br />

COMPOUND THAT INHIBITS ACTIVITY OF<br />

DIPEPTIDYL PEPTIDASE-IV, AND OTHER<br />

ANTIDIABETIC OR ANTIOBESITY AGENTS<br />

AS ACTIVE INGREDIENTS<br />

• COMPOSITION PHARMACEUTIQUE ET<br />

MEDICAMENT POUR LA PREVENTION ET<br />

LE TRAITEMENT DE DIABETES OU DE<br />

L'OBESITE COMPRENANT COMME PRIN-<br />

CIPE ACTIF, UN COMPOSE QUI INHIBE<br />

L'ACTIVATION DE DIPEPTIDYL PEPTI-<br />

DASE-IV<br />

(71) Dong-A Pharmaceutical Co., Ltd., 252<br />

Yongdu-dong Dongdaemun-ku, Seoul 130-<br />

072, KR<br />

(72) SHIN, Chang Yell, Seoul 132-691, KR<br />

CHOI, Song-Hyen, Suwon-si Gyeonggi-do<br />

443-372, KR<br />

CHAE, Yu Na, Yongin-si Gyeonggi-do 448-<br />

130, KR<br />

YANG, Eun Kyoung, Yongin-si Gyeonggi-do<br />

446-905, KR<br />

AHN, Gook Jun, Anseong-si Gyeonggi-do<br />

456-933, KR<br />

SON, Moon-Ho, Suwon-si Gyeonggi-do 442-<br />

070, KR<br />

KIM, Heung Jae, Seongnam-si Gyeonggi-do<br />

463-773, KR<br />

KWAK, Woo Young, Yongin-si Gyeonggi-do<br />

449-827, KR<br />

MIN, Jong Pil, Yongin-si Gyeonggi-do 446-<br />

760, KR<br />

YOON, Tae Hyun, Yongin-si Gyeonggi-do<br />

446-905, KR<br />

KIM, Soon Hoe, Suwon-si Gyeonggi-do 443-<br />

470, KR<br />

YOO, Moohi, Seoul 135-807, KR<br />

(74) Andrews, Timothy Stephen, et al, Marks &<br />

Clerk LLP 66-68 Hills Road, Cambridge CB2<br />

1LA, GB<br />

A61K <strong>31</strong>/498 → (51) A61K <strong>31</strong>/137<br />

A61K <strong>31</strong>/4985 → (51) A61K <strong>31</strong>/40<br />

A61K <strong>31</strong>/4985 → (51) A61K <strong>31</strong>/522<br />

A61K <strong>31</strong>/506 → (51) A61K <strong>31</strong>/551<br />

A61K <strong>31</strong>/506 → (51) C07D 235/16<br />

A61K <strong>31</strong>/517 → (51) C07D 401/14<br />

A61K <strong>31</strong>/519 → (51) A61K <strong>31</strong>/551<br />

A61K <strong>31</strong>/519 → (51) C07D 487/04<br />

A61K <strong>31</strong>/52 → (51) A61K <strong>31</strong>/551<br />

A61K <strong>31</strong>/52 → (51) C07D 401/14<br />

(51) A61K <strong>31</strong>/522 (11) 2 351 568 A2<br />

A61K <strong>31</strong>/4985 A61P 3/10<br />

A61P 9/04<br />

(25) De (26) De<br />

(21) 11156183.3 (22) 03.05.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

AL BA HR MK RS<br />

(27) 03.05.2007 EP 07728723<br />

(30) 04.05.2006 EP 06009203<br />

(54) • Verwendungen von dpp iv Inhibitoren<br />

• Uses of dpp-iv inhibitors<br />

• Utilisations d'inhibiteurs de l'enzyme dpp<br />

iv<br />

(71) Boehringer Ingelheim International GmbH,<br />

Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Straße 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(72) Dugi, Klaus, 01324, DRESDEN, DE<br />

Himmelsbach, Frank, 88441, MITTELBIBER-<br />

ACH, DE<br />

Mark, Michael, 88400, BIBERACH, DE<br />

(74) Hammann, Heinz, Boehringer Ingelheim<br />

GmbH CD-<strong>Patent</strong>s Binger Straße 173, 55216<br />

Ingelheim am Rhein, DE<br />

(62) 07728723.3 / 2 015 754<br />

A61K <strong>31</strong>/5377 → (51) C07D 235/16<br />

A61K <strong>31</strong>/538 → (51) A61K <strong>31</strong>/137<br />

(51) A61K <strong>31</strong>/551 (11) 2 351 569 A1<br />

A61K <strong>31</strong>/192 A61K <strong>31</strong>/343<br />

A61K <strong>31</strong>/4409 A61K <strong>31</strong>/506<br />

A61K <strong>31</strong>/519 A61K <strong>31</strong>/5578<br />

A61P 9/08 A61P 9/10<br />

A61P 9/12 A61K <strong>31</strong>/52<br />

(25) En (26) En<br />

(21) 11000632.7 (22) 25.10.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(30) 26.10.2005 US 730273 P<br />

(54) • Kombinationstherapie mit Fasudil zur<br />

Behandlung von pulmonaler Hypertonie<br />

• Fasudil in combination therapies for the<br />

treatment of pulmonary arterial hypertension<br />

• Fasudil dans des thérapies combinées pour<br />

le traitement de l'hypertension artérielle<br />

pulmonaire<br />

(71) Asahi Kasei Pharma Corporation, 1-105<br />

Kanda Jinbocho Chiyoda-ku, Tokyo 101-<br />

8101, JP<br />

(72) Fong, Benson, Brisbane CA 94005-1846, US<br />

(74) Forstmeyer, Dietmar, et al, BOETERS &<br />

LIECK Oberanger 32, 803<strong>31</strong> München, DE<br />

(62) 09007232.3 / 2 111 863<br />

06826765.7 / 1 951 253<br />

A61K <strong>31</strong>/5578 → (51) A61K <strong>31</strong>/551<br />

A61K <strong>31</strong>/573 → (51) A61K <strong>31</strong>/65<br />

A61K <strong>31</strong>/60 → (51) A61K <strong>31</strong>/05<br />

A61K <strong>31</strong>/64 → (51) A61K <strong>31</strong>/40<br />

(51) A61K <strong>31</strong>/65 (11) 2 351 570 A1<br />

A61K <strong>31</strong>/70 A61K <strong>31</strong>/165<br />

A61K <strong>31</strong>/44 A61K <strong>31</strong>/573<br />

A61P 29/00 A61P <strong>31</strong>/00<br />

(25) En (26) En<br />

(21) 10185616.9 (22) 27.11.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(27) 27.11.2001 PCT/US01/44<strong>31</strong>5<br />

(30) 27.11.2000 US 723064<br />

(54) • Antibiotikum-/Analgesikumformulierung<br />

und Verfahren zur Herstellung dieser<br />

Formulierung<br />

• An Antibiotic/Analgesic Formulation And a<br />

Method of Making This Formulation<br />

383<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>31</strong>/<strong>2011</strong>) 03.08.<strong>2011</strong><br />

• Formulation antibiotique/analgésique et<br />

son procédé de fabrication<br />

(71) IVX Animal Health, Inc., 3915 South 48th<br />

Street Terrace, St. Joseph MO 64503, US<br />

(72) Mihalik, Richard, St Joseph, MO 64501, US<br />

(74) Turner, Craig Robert, A.A. Thornton & Co.<br />

235 High Holborn, London WC1V 7LE, GB<br />

(62) 01997308.0 / 1 345 611<br />

A61K <strong>31</strong>/661 → (51) A61K <strong>31</strong>/137<br />

A61K <strong>31</strong>/661 → (51) C07C 217/84<br />

(51) A61K <strong>31</strong>/695 (11) 2 351 571 A1<br />

A61P 35/00 A61P 43/00<br />

C07F 7/18<br />

(25) Ja (26) En<br />

(21) 09818941.8 (22) 02.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2009/005128 02.10.2009<br />

(87) WO 2010/041401 2010/15 15.04.2010<br />

(30) 09.10.2008 JP 2008262646<br />

(54) • PROTEINPHOSPHATASEHEMMER<br />

• PROTEIN PHOSPHATASE INHIBITOR<br />

• INHIBITEUR DE PROTÉINE PHOSPHATASE<br />

(71) LSIP, LLC, 7-12, Marunouchi 1-chome,<br />

Chiyoda-ku Tokyo 100-0005, JP<br />

(72) SAKAGUCHI, Kazuyasu, , JP<br />

TANINO, Keiji, , JP<br />

CHUMAN, Yoshiro, , JP<br />

YOSHIMURA, Fumihiko, , JP<br />

YAGI, Hiroaki, , JP<br />

(74) von Kreisler Selting Werner, <strong>Patent</strong>anwälte<br />

Deichmannhaus am Dom Bahnhofsvorplatz<br />

1, 50667 Köln, DE<br />

A61K <strong>31</strong>/70 → (51) A61K <strong>31</strong>/65<br />

A61K <strong>31</strong>/7016 → (51) C12P 19/44<br />

A61K <strong>31</strong>/7024 → (51) C07H 13/06<br />

A61K <strong>31</strong>/7088 → (51) A61K 45/00<br />

A61K <strong>31</strong>/7105 → (51) A61K 45/00<br />

A61K <strong>31</strong>/7115 → (51) A61K 45/00<br />

A61K <strong>31</strong>/713 → (51) C12N 15/00<br />

A61K 35/74 → (51) A23L 1/29<br />

A61K 35/74 → (51) A23L 3/3571<br />

A61K 36/00 → (51) A61K 36/53<br />

A61K 36/18 → (51) A61K <strong>31</strong>/05<br />

(51) A61K 36/53 (11) 2 351 572 A1<br />

A23L 1/30 A61K 36/00<br />

A61P 1/04 A61P <strong>31</strong>/04<br />

A61P 35/00<br />

(25) Ja (26) En<br />

(21) 09823693.8 (22) 30.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2009/068668 30.10.2009<br />

(87) WO 2010/050583 2010/18 06.05.2010<br />

(30) 30.10.2008 JP 2008279358<br />

(54) • MITTEL GEGEN HELICOBACTER PYLORI<br />

• AGENT HAVING ANTI-HELICOBACTER<br />

PYLORI ACTIVITY<br />

• AGENT AYANT UNE ACTIVITÉ ANTI-HELI-<br />

COBACTER PYLORI

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!